Saturday 17 October 2026 Export KMDA’s income statement to Excel — free account

Kamada Ltd.

KMDA Healthcare Drug Manufacturers Specialty & Generic

Kamada Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $180.5 million, up 12.1% from fiscal 2024. In the quarter to June 2026, revenue grew 22.7%, EPS grew 23.1%, free cash flow grew 165.7% and total debt fell 38.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

7.77 0.06 −0.77%

Follow KMDA

Alert me

Market cap: $451.7M
P/E: 20.4×
Fwd P/E: 0.0×
Dividend yield: 5.41%
F-score: 7/9
Altman Z: 3.33
Beneish M: −2.35
Dividend safety: 50/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	19.32	23.83	20.17	19.28	+8 more quarters Free account
P/S ratio Full definition →	2.21	2.71	2.26	2.34
P/FCF ratio Full definition →	16.15	30.09	26.00	22.27
P/Operating CF Full definition →	23.52	(1,691.74)	53.79	39.21
P/B ratio Full definition →	1.58	1.90	1.51	1.54
Price to Tangible BV Full definition →	1.78	2.15	1.70	1.74
EV/Sales Full definition →	1.94	2.42	1.95	2.05
EV/EBITDA Full definition →	8.61	10.86	8.56	8.32
EV/Operating CF Full definition →	10.39	17.13	13.82	12.63
EV/FCF Full definition →	14.12	26.93	22.50	19.51
Quick Ratio Full definition →	2.29	1.90	2.28	2.24
Current Ratio Full definition →	4.06	3.33	4.07	4.03
Net Debt/EBITDA Full definition →	(4.78)	(5.79)	(8.92)	(5.31)
Debt/Assets Full definition →	1.57%	2.78%	2.62%	2.81%
Debt/Equity Full definition →	0.02	0.04	0.04	0.04
Asset Turnover Full definition →	0.51	0.48	0.48	0.48
Operating CF/Net income Full definition →	1.95	(0.07)	2.12	1.97
Capex/Depreciation Full definition →	(0.54)	(0.25)	(0.73)	(0.95)
Interest Coverage Full definition →	25.63	36.98	13.71	35.37
Research and Development Expense of Revenue Full definition →	4.01%	4.82%	6.48%	5.61%
Selling, General and Administrative Expense of Revenue Full definition →	19.59%	22.06%	23.55%	19.83%
Intangible Assets out of Total Assets Full definition →	0.08	0.08	0.08	0.08
Share Based Compensation of Revenue Full definition →	1.31%	1.77%	1.03%	0.25%
Graham Net Nets Full definition →	0.20	0.15	0.21	0.20
Graham Number Full definition →	6.31	5.88	6.06	6.04
Earnings Yield Full definition →	5.18%	4.20%	4.96%	5.19%
Free Cash Flow Yield Full definition →	6.19%	3.32%	3.85%	4.49%
Revenue per Share Full definition →	0.95	0.77	0.78	0.80
Operating CF per Share Full definition →	0.31	0.00	0.13	0.18
Capex per Share Full definition →	(0.04)	(0.02)	(0.05)	(0.06)
Free Cash Flow per Share Full definition →	0.28	(0.02)	0.08	0.12
Cash per Share Full definition →	1.21	1.24	1.31	1.22
Shareholders Equity per Share Full definition →	4.66	4.39	4.67	4.51
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	4.66	4.39	4.67	4.51
Free Cash Flow Full definition →	15.96	(1.26)	4.79	6.83
Working Capital Full definition →	150.42	139.46	145.68	144.90
Capital Expenditures Full definition →	(2.11)	(0.97)	(2.77)	(3.59)
Net Current Asset Value Full definition →	85.97	75.60	83.44	80.76
EV/EBIT Full definition →	13.35	17.35	13.42	12.89
Capex to Sales Full definition →	0.04	0.02	0.06	0.08
Price to Operating Income Full definition →	15.27	19.39	15.51	14.71
Other line items
Average Receivables Full definition →	38.89	37.27	29.88	28.09
Average Payables Full definition →	37.28	45.52	36.38	28.60
Average Inventory Full definition →	84.48	81.90	81.88	78.49
Average Assets Full definition →	375.67	379.06	375.48	364.21
Average Common Equity Full definition →	264.76	255.67	264.27	260.25

Fold the line items

Columns are period end dates

Stockrow Weekly